Recombinant tissue plasminogen activator injections for fibrin-specific thrombolysis in acute ischemic stroke, myocardial infarction, and pulmonary embolism. Administered in stroke units and emergency rooms by neurologists and emergency physicians. Supplied by biotech manufacturers to acute care facilities for time-sensitive therapies.